First Modification to Subcontract Agreement Between The Children’s Hospital of Philadelphia and Targeted Genetics Corporation for NIH HIV Vaccine Project
Contract Categories:
Business Finance
›
Modification Agreements
Summary
This document modifies the subcontract agreement between The Children’s Hospital of Philadelphia (CHOP) and Targeted Genetics Corporation for the NIH-funded HIV Vaccine Design and Development Teams project. The modification extends the project period to August 30, 2007, and increases the total authorized costs to $8,794,877 for the new year. All other terms of the original agreement remain unchanged. The modification is signed by authorized representatives of both organizations.
EX-10.1 2 v056227_ex10-1.htm
![]() | The Children’s Hospital of Philadelphia Joseph Stokes, Jr., Research Institute Department of Sponsored Projects 3615 Civic Center Blvd. ARC 142 Philadelphia, PA 19104-4318 Phone ###-###-#### |
CHOP Reference No. 22852-02-01
MODIFICATION OF AGREEMENT
Modification of the Subcontract Agreement with the Targeted Genetics Corporation under the National Institute of Health Contract Award # HHSN2662005000008C, for support of a project entitled “HIV Vaccine Design and Development Teams”, with Dr. Philip Johnson serving as the Principal Investigator for CHOP and Drs. Barrie Carter and Pervin Anklesaria serving as the Project Directors for the Subawardee.
Modification # 1
This modification changed the following paragraphs as detailed below:
Article 2 Period of Performance. | Add new period of performance: 8/31/06 to 8/30/07 | |
Article 4.1 Estimated Costs | Authorize additional costs for new year. Total costs for the new performance period are amended from $3,087,023 to add $5,707,854 for Year-2 shall not exceed $8,794,877 as detailed in new Attachment A. | |
All other terms and conditions remain unchanged. |
CHOP Organizational Official | Targeted Genetics Corporation Organizational Official | ||||
Name: | Sara Dubberly | Name: | Barrie Carter | ||
Title: | Director, Dept. of Sponsored Projects | Title: | Senior Executive Vice President and Chief Scientific Officer | ||
Institution: | The Children's Hospital of Philadelphia | Institution: | Targeted Genetics Corporation | ||
The Joseph Stokes Jr. Research Institute | | ||||
Address: | 3615 Civic Center Boulevard | Address: | 1100 Olive Way, Suite 100 | ||
City, State: | Philadelphia, PA | City, State: | Seattle, WA | ||
Zip: | 19104-4318 | Zip: | 98101 | ||
Signature: | /s/ Sara Dubberly | Signature: | /s/ Barrie Carter | ||
Date: | October 27, 2006 | Date: | October 19, 2006 |
The Children’s Hospital of Philadelphia
![]() | The Children’s Hospital of Philadelphia Joseph Stokes, Jr., Research Institute Department of Sponsored Projects 3615 Civic Center Blvd. ARC 142 Philadelphia, PA 19104-4318 Phone ###-###-#### |
ATTACHMENT A
Budget | ||||
Total Costs | $ | 8,794,877 |
The Children’s Hospital of Philadelphia